Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
May 4, 2021 2:01 PM EDT
Truist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.
The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More
May 4, 2021 2:00 PM EDT
Needham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 1Q21 revenue and EPS beat consensus. ZBH's underlying revenue growth improved in 1Q21, which we believe was... More
May 3, 2021 7:17 AM EDT
Christopher Harvey, a senior research analyst at Wells Fargo, unveiled today the "Signature Picks" portfolio consisting of 35 stocks.
A portfolio, accessible under the Bloomberg ticker WFSSBEST Index, highlighting the banks "best stock ideas in a diversified, risk-adjusted package." The goal is to outperform the S&P500 over a 1-year period via stock selection, not sector rotation, Harvey writes in a note.
Signature Picks has no preordained style/factor biases (unlike our former model portfolio, the QQP). It is designed to be an eclectic/opportunistic portfolio with a... More
